 Rachel Frank
Concepts (832)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroscopy | 57 | 2025 | 222 | 10.090 |
Why?
| | Shoulder Joint | 50 | 2024 | 173 | 9.640 |
Why?
| | Joint Instability | 36 | 2024 | 167 | 8.990 |
Why?
| | Cartilage, Articular | 21 | 2025 | 311 | 4.840 |
Why?
| | Knee Injuries | 18 | 2022 | 99 | 4.710 |
Why?
| | Knee Joint | 29 | 2025 | 409 | 4.630 |
Why?
| | Tibial Meniscus Injuries | 12 | 2025 | 48 | 4.630 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 16 | 2025 | 143 | 4.520 |
Why?
| | Biological Products | 12 | 2024 | 216 | 4.470 |
Why?
| | Orthopedic Procedures | 19 | 2021 | 216 | 4.370 |
Why?
| | Shoulder Dislocation | 16 | 2023 | 49 | 4.220 |
Why?
| | Menisci, Tibial | 17 | 2025 | 61 | 4.130 |
Why?
| | Anterior Cruciate Ligament Injuries | 16 | 2025 | 159 | 3.680 |
Why?
| | Sports Medicine | 10 | 2023 | 112 | 3.640 |
Why?
| | Tibia | 13 | 2025 | 178 | 3.490 |
Why?
| | Athletic Injuries | 20 | 2023 | 529 | 3.330 |
Why?
| | Bone Transplantation | 13 | 2025 | 90 | 3.320 |
Why?
| | Platelet-Rich Plasma | 13 | 2025 | 32 | 3.310 |
Why?
| | Orthopedics | 12 | 2025 | 144 | 3.140 |
Why?
| | Simulation Training | 6 | 2024 | 106 | 2.990 |
Why?
| | Femoracetabular Impingement | 8 | 2018 | 35 | 2.950 |
Why?
| | Rotator Cuff Injuries | 11 | 2023 | 60 | 2.570 |
Why?
| | Osteotomy | 11 | 2025 | 119 | 2.550 |
Why?
| | Hip Joint | 8 | 2018 | 171 | 2.380 |
Why?
| | Tenodesis | 8 | 2020 | 20 | 2.370 |
Why?
| | Cartilage Diseases | 5 | 2019 | 39 | 2.360 |
Why?
| | Reoperation | 29 | 2023 | 573 | 2.290 |
Why?
| | Arthroplasty | 10 | 2020 | 52 | 2.270 |
Why?
| | Osteoarthritis, Knee | 15 | 2025 | 254 | 2.150 |
Why?
| | Meniscus | 4 | 2023 | 22 | 2.140 |
Why?
| | Allografts | 18 | 2025 | 146 | 2.020 |
Why?
| | Shoulder Injuries | 9 | 2024 | 58 | 1.990 |
Why?
| | Humans | 297 | 2025 | 137585 | 1.960 |
Why?
| | Shoulder | 22 | 2023 | 89 | 1.800 |
Why?
| | Return to Sport | 10 | 2025 | 97 | 1.750 |
Why?
| | Arthroplasty, Replacement, Shoulder | 9 | 2020 | 33 | 1.740 |
Why?
| | Cartilage | 10 | 2025 | 188 | 1.710 |
Why?
| | Computer Simulation | 6 | 2021 | 978 | 1.700 |
Why?
| | Arthroplasty, Replacement, Knee | 8 | 2023 | 363 | 1.640 |
Why?
| | Transplantation, Homologous | 18 | 2025 | 416 | 1.630 |
Why?
| | Sports | 7 | 2023 | 231 | 1.610 |
Why?
| | Tendons | 10 | 2020 | 111 | 1.600 |
Why?
| | Clinical Competence | 8 | 2024 | 1118 | 1.560 |
Why?
| | Suture Anchors | 7 | 2021 | 33 | 1.540 |
Why?
| | Musculoskeletal Diseases | 5 | 2024 | 78 | 1.530 |
Why?
| | Scapula | 11 | 2023 | 46 | 1.500 |
Why?
| | Athletes | 7 | 2023 | 423 | 1.500 |
Why?
| | Acromioclavicular Joint | 3 | 2023 | 11 | 1.490 |
Why?
| | Patient Reported Outcome Measures | 10 | 2025 | 402 | 1.450 |
Why?
| | Tendon Injuries | 5 | 2019 | 68 | 1.400 |
Why?
| | Postoperative Complications | 24 | 2022 | 2654 | 1.370 |
Why?
| | Adult | 126 | 2025 | 37929 | 1.280 |
Why?
| | Second-Look Surgery | 3 | 2025 | 7 | 1.230 |
Why?
| | Femur | 9 | 2025 | 254 | 1.220 |
Why?
| | Treatment Outcome | 49 | 2025 | 10811 | 1.170 |
Why?
| | Young Adult | 50 | 2025 | 13209 | 1.160 |
Why?
| | Humeral Head | 7 | 2023 | 14 | 1.150 |
Why?
| | Male | 157 | 2025 | 67762 | 1.120 |
Why?
| | Bankart Lesions | 4 | 2023 | 9 | 1.120 |
Why?
| | Evidence-Based Medicine | 7 | 2020 | 740 | 1.110 |
Why?
| | Arthroplasty, Subchondral | 4 | 2018 | 7 | 1.100 |
Why?
| | Rotator Cuff | 8 | 2023 | 47 | 1.080 |
Why?
| | Anterior Cruciate Ligament | 9 | 2023 | 81 | 1.070 |
Why?
| | Internship and Residency | 8 | 2024 | 1147 | 1.070 |
Why?
| | Female | 152 | 2025 | 73304 | 1.040 |
Why?
| | Bone Screws | 5 | 2020 | 103 | 1.030 |
Why?
| | Bone Malalignment | 2 | 2025 | 13 | 1.030 |
Why?
| | Middle Aged | 104 | 2025 | 33479 | 1.020 |
Why?
| | Joint Dislocations | 2 | 2024 | 50 | 1.020 |
Why?
| | Female Athlete Triad Syndrome | 2 | 2017 | 8 | 1.020 |
Why?
| | Education, Medical, Graduate | 5 | 2019 | 486 | 1.010 |
Why?
| | Ligaments, Articular | 5 | 2023 | 51 | 1.010 |
Why?
| | Hemiarthroplasty | 3 | 2020 | 8 | 0.980 |
Why?
| | Osteoarthritis | 7 | 2019 | 185 | 0.980 |
Why?
| | Range of Motion, Articular | 17 | 2023 | 393 | 0.960 |
Why?
| | Orthopedic Surgeons | 2 | 2023 | 27 | 0.930 |
Why?
| | Achilles Tendon | 2 | 2023 | 32 | 0.900 |
Why?
| | Follow-Up Studies | 37 | 2021 | 5131 | 0.890 |
Why?
| | Biomechanical Phenomena | 16 | 2023 | 810 | 0.850 |
Why?
| | Blood Loss, Surgical | 2 | 2014 | 101 | 0.850 |
Why?
| | Quadriceps Muscle | 2 | 2023 | 133 | 0.830 |
Why?
| | Cadaver | 13 | 2020 | 296 | 0.830 |
Why?
| | Adolescent | 73 | 2024 | 21513 | 0.790 |
Why?
| | Social Media | 2 | 2024 | 158 | 0.780 |
Why?
| | Venous Thrombosis | 2 | 2022 | 190 | 0.750 |
Why?
| | Retrospective Studies | 56 | 2021 | 15657 | 0.750 |
Why?
| | Lacerations | 1 | 2022 | 35 | 0.740 |
Why?
| | Pain | 6 | 2018 | 756 | 0.730 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2014 | 177 | 0.730 |
Why?
| | Golf | 1 | 2020 | 7 | 0.680 |
Why?
| | Bone Resorption | 3 | 2018 | 86 | 0.670 |
Why?
| | Rupture | 8 | 2023 | 92 | 0.670 |
Why?
| | Skiing | 1 | 2021 | 47 | 0.670 |
Why?
| | Radiography | 16 | 2019 | 822 | 0.660 |
Why?
| | Brain Concussion | 4 | 2023 | 574 | 0.650 |
Why?
| | Suture Techniques | 8 | 2019 | 122 | 0.640 |
Why?
| | Hamstring Muscles | 2 | 2018 | 20 | 0.640 |
Why?
| | Aged | 72 | 2025 | 23961 | 0.630 |
Why?
| | Internet | 3 | 2022 | 655 | 0.630 |
Why?
| | Physical Examination | 9 | 2018 | 241 | 0.610 |
Why?
| | Hypertension | 11 | 2023 | 1295 | 0.610 |
Why?
| | Humerus | 7 | 2020 | 39 | 0.610 |
Why?
| | Virtual Reality | 1 | 2019 | 61 | 0.580 |
Why?
| | Tenotomy | 1 | 2018 | 15 | 0.570 |
Why?
| | Kidney Transplantation | 6 | 2024 | 708 | 0.570 |
Why?
| | Swimming | 1 | 2018 | 51 | 0.570 |
Why?
| | Prosthesis Failure | 5 | 2015 | 123 | 0.570 |
Why?
| | Pain, Postoperative | 2 | 2018 | 265 | 0.560 |
Why?
| | Adipose Tissue | 6 | 2025 | 635 | 0.560 |
Why?
| | Yoga | 1 | 2018 | 31 | 0.560 |
Why?
| | Venous Thromboembolism | 1 | 2022 | 316 | 0.560 |
Why?
| | Glenoid Cavity | 2 | 2015 | 7 | 0.550 |
Why?
| | Carcinoma, Renal Cell | 4 | 2019 | 217 | 0.550 |
Why?
| | Facial Recognition | 1 | 2018 | 32 | 0.550 |
Why?
| | Treatment Failure | 6 | 2020 | 356 | 0.550 |
Why?
| | Leg Injuries | 1 | 2017 | 25 | 0.550 |
Why?
| | Facial Expression | 1 | 2018 | 72 | 0.540 |
Why?
| | Bone Density | 2 | 2021 | 489 | 0.540 |
Why?
| | Fractures, Stress | 1 | 2017 | 34 | 0.540 |
Why?
| | Imaging, Three-Dimensional | 4 | 2018 | 580 | 0.540 |
Why?
| | Stress, Mechanical | 3 | 2019 | 485 | 0.540 |
Why?
| | Bundle of His | 1 | 2017 | 18 | 0.530 |
Why?
| | Olecranon Process | 1 | 2017 | 7 | 0.530 |
Why?
| | Ulna Fractures | 1 | 2017 | 13 | 0.530 |
Why?
| | Muscle, Skeletal | 8 | 2020 | 1724 | 0.530 |
Why?
| | Prosthesis-Related Infections | 2 | 2015 | 95 | 0.530 |
Why?
| | Mesenchymal Stem Cell Transplantation | 3 | 2025 | 52 | 0.530 |
Why?
| | Fractures, Ununited | 1 | 2017 | 27 | 0.520 |
Why?
| | Bicycling | 1 | 2017 | 114 | 0.520 |
Why?
| | Injections, Intra-Articular | 9 | 2025 | 49 | 0.520 |
Why?
| | Open Fracture Reduction | 1 | 2017 | 31 | 0.520 |
Why?
| | Social Perception | 1 | 2018 | 108 | 0.520 |
Why?
| | Hip | 3 | 2014 | 56 | 0.520 |
Why?
| | Cumulative Trauma Disorders | 1 | 2017 | 42 | 0.510 |
Why?
| | Consensus | 6 | 2025 | 683 | 0.510 |
Why?
| | Atrioventricular Block | 1 | 2017 | 37 | 0.510 |
Why?
| | Chondrocytes | 2 | 2018 | 212 | 0.510 |
Why?
| | Databases, Factual | 10 | 2019 | 1357 | 0.510 |
Why?
| | Osteosarcoma | 2 | 2015 | 74 | 0.490 |
Why?
| | Soft Tissue Injuries | 1 | 2016 | 33 | 0.480 |
Why?
| | Kidney Neoplasms | 4 | 2019 | 403 | 0.480 |
Why?
| | Patellar Ligament | 2 | 2014 | 27 | 0.480 |
Why?
| | Transplantation, Autologous | 6 | 2023 | 238 | 0.470 |
Why?
| | Stereotyping | 1 | 2015 | 45 | 0.470 |
Why?
| | Electrocardiography | 5 | 2017 | 629 | 0.470 |
Why?
| | Comprehension | 2 | 2014 | 172 | 0.470 |
Why?
| | Bone-Patellar Tendon-Bone Grafts | 1 | 2014 | 2 | 0.460 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2017 | 130 | 0.460 |
Why?
| | Prejudice | 1 | 2015 | 73 | 0.460 |
Why?
| | Cohort Studies | 14 | 2023 | 5742 | 0.450 |
Why?
| | Ilium | 1 | 2014 | 25 | 0.450 |
Why?
| | Incidence | 12 | 2022 | 2804 | 0.450 |
Why?
| | Fracture Fixation, Internal | 1 | 2017 | 188 | 0.450 |
Why?
| | Arthroplasty, Replacement | 5 | 2016 | 45 | 0.450 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 5 | 2023 | 85 | 0.440 |
Why?
| | Patient Education as Topic | 4 | 2024 | 766 | 0.440 |
Why?
| | Hip Injuries | 1 | 2014 | 15 | 0.440 |
Why?
| | Patellofemoral Joint | 2 | 2023 | 9 | 0.430 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2014 | 752 | 0.430 |
Why?
| | Retroperitoneal Neoplasms | 2 | 2013 | 25 | 0.420 |
Why?
| | Hip Prosthesis | 1 | 2014 | 46 | 0.420 |
Why?
| | Patient Satisfaction | 3 | 2018 | 660 | 0.420 |
Why?
| | Materials Testing | 2 | 2017 | 356 | 0.410 |
Why?
| | Delphi Technique | 9 | 2025 | 280 | 0.410 |
Why?
| | Time-to-Treatment | 1 | 2015 | 205 | 0.410 |
Why?
| | Computer-Assisted Instruction | 1 | 2013 | 66 | 0.410 |
Why?
| | Models, Educational | 1 | 2013 | 93 | 0.410 |
Why?
| | Child | 49 | 2024 | 21935 | 0.410 |
Why?
| | Graft Survival | 6 | 2019 | 535 | 0.400 |
Why?
| | Bone and Bones | 1 | 2016 | 317 | 0.400 |
Why?
| | Recurrence | 15 | 2023 | 1060 | 0.400 |
Why?
| | Liposarcoma | 1 | 2013 | 27 | 0.400 |
Why?
| | Pain Management | 2 | 2014 | 352 | 0.400 |
Why?
| | Models, Anatomic | 1 | 2013 | 93 | 0.400 |
Why?
| | Pain Measurement | 9 | 2025 | 521 | 0.390 |
Why?
| | Emotions | 1 | 2018 | 548 | 0.390 |
Why?
| | Postoperative Period | 8 | 2019 | 342 | 0.390 |
Why?
| | Risk Factors | 24 | 2024 | 10388 | 0.390 |
Why?
| | Education, Medical, Continuing | 1 | 2013 | 127 | 0.390 |
Why?
| | Blood Pressure | 8 | 2024 | 1786 | 0.390 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2013 | 57 | 0.390 |
Why?
| | Autism Spectrum Disorder | 1 | 2018 | 395 | 0.390 |
Why?
| | Femur Neck | 1 | 2012 | 61 | 0.380 |
Why?
| | Femur Head | 1 | 2012 | 42 | 0.380 |
Why?
| | Acetabulum | 2 | 2014 | 109 | 0.380 |
Why?
| | Ozone | 3 | 2001 | 132 | 0.380 |
Why?
| | Nephrectomy | 2 | 2013 | 169 | 0.380 |
Why?
| | Universities | 1 | 2014 | 433 | 0.370 |
Why?
| | Magnetic Resonance Imaging | 6 | 2025 | 3566 | 0.370 |
Why?
| | Musculoskeletal System | 2 | 2022 | 48 | 0.360 |
Why?
| | Rotation | 3 | 2018 | 117 | 0.360 |
Why?
| | Hyaluronic Acid | 7 | 2025 | 225 | 0.350 |
Why?
| | Tomography, X-Ray Computed | 9 | 2020 | 2691 | 0.350 |
Why?
| | Age Factors | 11 | 2019 | 3295 | 0.350 |
Why?
| | Nephrotic Syndrome | 4 | 2022 | 39 | 0.350 |
Why?
| | Activities of Daily Living | 4 | 2018 | 413 | 0.330 |
Why?
| | Surveys and Questionnaires | 8 | 2022 | 5778 | 0.330 |
Why?
| | Football | 3 | 2017 | 85 | 0.330 |
Why?
| | Aged, 80 and over | 22 | 2021 | 7635 | 0.320 |
Why?
| | Stem Cell Transplantation | 3 | 2020 | 176 | 0.320 |
Why?
| | Random Allocation | 4 | 2019 | 353 | 0.320 |
Why?
| | Joint Prosthesis | 3 | 2015 | 21 | 0.320 |
Why?
| | Reproducibility of Results | 9 | 2024 | 3284 | 0.310 |
Why?
| | Meniscectomy | 2 | 2019 | 8 | 0.310 |
Why?
| | Health Care Surveys | 3 | 2017 | 565 | 0.310 |
Why?
| | United States | 21 | 2024 | 14841 | 0.310 |
Why?
| | Pilot Projects | 7 | 2021 | 1710 | 0.310 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2023 | 131 | 0.290 |
Why?
| | Sex Factors | 6 | 2019 | 2071 | 0.290 |
Why?
| | Physical Therapy Modalities | 3 | 2023 | 308 | 0.290 |
Why?
| | Body Mass Index | 5 | 2019 | 2389 | 0.280 |
Why?
| | Patient Readmission | 3 | 2018 | 697 | 0.270 |
Why?
| | Mass Screening | 2 | 2014 | 1287 | 0.270 |
Why?
| | Joint Diseases | 3 | 2019 | 60 | 0.260 |
Why?
| | Nephrology | 2 | 2024 | 61 | 0.260 |
Why?
| | Glomerulosclerosis, Focal Segmental | 4 | 2016 | 47 | 0.260 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2017 | 66 | 0.250 |
Why?
| | Arthralgia | 2 | 2025 | 56 | 0.250 |
Why?
| | Patient Positioning | 2 | 2019 | 67 | 0.250 |
Why?
| | Infant Mortality | 2 | 2004 | 116 | 0.250 |
Why?
| | Video Recording | 2 | 2024 | 180 | 0.240 |
Why?
| | Matched-Pair Analysis | 2 | 2016 | 39 | 0.240 |
Why?
| | Electrocoagulation | 4 | 2014 | 40 | 0.230 |
Why?
| | Pulmonary Embolism | 3 | 2018 | 226 | 0.230 |
Why?
| | Wound Healing | 3 | 2013 | 331 | 0.230 |
Why?
| | Complement Activation | 2 | 2025 | 415 | 0.230 |
Why?
| | Humeral Fractures | 2 | 2017 | 47 | 0.230 |
Why?
| | Tachycardia, Ventricular | 4 | 2000 | 175 | 0.220 |
Why?
| | Viscosupplements | 3 | 2020 | 11 | 0.220 |
Why?
| | Time Factors | 18 | 2019 | 6828 | 0.220 |
Why?
| | Catheter Ablation | 5 | 2000 | 350 | 0.220 |
Why?
| | Complement Factor H | 1 | 2025 | 80 | 0.220 |
Why?
| | Risk Assessment | 8 | 2020 | 3457 | 0.220 |
Why?
| | Synovial Membrane | 1 | 2025 | 117 | 0.220 |
Why?
| | Clinical Trials as Topic | 2 | 2020 | 1050 | 0.220 |
Why?
| | Reading | 3 | 2014 | 135 | 0.220 |
Why?
| | Curriculum | 2 | 2021 | 992 | 0.220 |
Why?
| | Caffeine | 1 | 2024 | 68 | 0.220 |
Why?
| | Patellar Dislocation | 1 | 2023 | 6 | 0.220 |
Why?
| | Prognosis | 13 | 2020 | 4030 | 0.210 |
Why?
| | Bone Marrow | 3 | 2023 | 286 | 0.210 |
Why?
| | Prospective Studies | 10 | 2023 | 7604 | 0.210 |
Why?
| | Prehypertension | 1 | 2023 | 28 | 0.210 |
Why?
| | Heart Ventricles | 5 | 2019 | 788 | 0.210 |
Why?
| | Sutures | 3 | 2019 | 58 | 0.200 |
Why?
| | Urolithiasis | 2 | 2016 | 9 | 0.200 |
Why?
| | Debridement | 4 | 2017 | 81 | 0.200 |
Why?
| | Ankle Injuries | 1 | 2023 | 65 | 0.200 |
Why?
| | Postoperative Care | 4 | 2019 | 261 | 0.190 |
Why?
| | Recovery of Function | 7 | 2019 | 653 | 0.190 |
Why?
| | Intra-Articular Fractures | 2 | 2019 | 19 | 0.190 |
Why?
| | Oxidants, Photochemical | 1 | 2001 | 8 | 0.190 |
Why?
| | Research Design | 2 | 2018 | 1139 | 0.180 |
Why?
| | Preoperative Period | 2 | 2018 | 129 | 0.180 |
Why?
| | Urinary Diversion | 2 | 1998 | 12 | 0.180 |
Why?
| | Osteoarthritis, Hip | 1 | 2021 | 45 | 0.180 |
Why?
| | Verbal Learning | 2 | 2007 | 60 | 0.180 |
Why?
| | Knee Dislocation | 1 | 2021 | 7 | 0.180 |
Why?
| | Biology | 1 | 2022 | 88 | 0.180 |
Why?
| | Arm | 2 | 2019 | 104 | 0.180 |
Why?
| | Ankle | 2 | 2019 | 60 | 0.180 |
Why?
| | Drug Chronotherapy | 1 | 2020 | 1 | 0.170 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2111 | 0.170 |
Why?
| | Operating Rooms | 2 | 2024 | 123 | 0.170 |
Why?
| | Comorbidity | 5 | 2018 | 1622 | 0.170 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1477 | 0.170 |
Why?
| | Arthritis, Rheumatoid | 4 | 2025 | 1167 | 0.170 |
Why?
| | Socioeconomic Factors | 2 | 2004 | 1289 | 0.170 |
Why?
| | Antihypertensive Agents | 2 | 2020 | 494 | 0.170 |
Why?
| | Echocardiography | 4 | 2020 | 642 | 0.170 |
Why?
| | Marketing of Health Services | 1 | 2020 | 14 | 0.170 |
Why?
| | Multiple Trauma | 1 | 2021 | 100 | 0.160 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 1 | 2000 | 57 | 0.160 |
Why?
| | Artificial Intelligence | 1 | 2023 | 279 | 0.160 |
Why?
| | Direct-to-Consumer Advertising | 1 | 2020 | 6 | 0.160 |
Why?
| | Autografts | 2 | 2023 | 44 | 0.160 |
Why?
| | Algorithms | 3 | 2023 | 1704 | 0.160 |
Why?
| | Absorptiometry, Photon | 1 | 2021 | 259 | 0.160 |
Why?
| | Delayed Graft Function | 2 | 2018 | 33 | 0.160 |
Why?
| | Osteonecrosis | 1 | 2020 | 24 | 0.160 |
Why?
| | Kidney | 7 | 2016 | 1468 | 0.160 |
Why?
| | Spinal Neoplasms | 1 | 2019 | 32 | 0.160 |
Why?
| | Intraoperative Complications | 2 | 2012 | 138 | 0.160 |
Why?
| | Bone Substitutes | 1 | 2019 | 28 | 0.160 |
Why?
| | Kidney Diseases | 3 | 2024 | 408 | 0.150 |
Why?
| | Cross-Sectional Studies | 8 | 2024 | 5472 | 0.150 |
Why?
| | Tensile Strength | 1 | 2019 | 97 | 0.150 |
Why?
| | Workers' Compensation | 1 | 2019 | 27 | 0.150 |
Why?
| | Surgeons | 1 | 2023 | 297 | 0.150 |
Why?
| | Pudendal Nerve | 1 | 2018 | 2 | 0.150 |
Why?
| | Shoulder Impingement Syndrome | 2 | 2018 | 7 | 0.150 |
Why?
| | Acromion | 2 | 2017 | 8 | 0.140 |
Why?
| | Visual Analog Scale | 1 | 2018 | 33 | 0.140 |
Why?
| | Graft Rejection | 3 | 2018 | 624 | 0.140 |
Why?
| | Odds Ratio | 2 | 2018 | 1070 | 0.140 |
Why?
| | Osteochondritis Dissecans | 1 | 2018 | 9 | 0.140 |
Why?
| | Prosthesis Design | 3 | 2015 | 327 | 0.140 |
Why?
| | Thinness | 1 | 2018 | 91 | 0.140 |
Why?
| | Radius | 1 | 2018 | 39 | 0.140 |
Why?
| | Ambulatory Care Facilities | 1 | 2020 | 232 | 0.140 |
Why?
| | Mycophenolic Acid | 3 | 2008 | 117 | 0.140 |
Why?
| | Sleep Wake Disorders | 1 | 2021 | 286 | 0.140 |
Why?
| | Urinary Bladder Diseases | 1 | 1998 | 19 | 0.140 |
Why?
| | Arthrography | 1 | 2017 | 17 | 0.140 |
Why?
| | Spine | 1 | 2019 | 173 | 0.140 |
Why?
| | Immunosuppressive Agents | 3 | 2008 | 890 | 0.140 |
Why?
| | Bone Marrow Transplantation | 1 | 2019 | 286 | 0.140 |
Why?
| | Length of Stay | 3 | 2018 | 1215 | 0.140 |
Why?
| | Hospital Charges | 1 | 2017 | 44 | 0.140 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 307 | 0.130 |
Why?
| | Multiple Sclerosis | 3 | 2008 | 455 | 0.130 |
Why?
| | Bronchi | 2 | 1996 | 260 | 0.130 |
Why?
| | Anticoagulants | 1 | 2022 | 664 | 0.130 |
Why?
| | Nephrons | 1 | 2016 | 18 | 0.130 |
Why?
| | Hypercalciuria | 1 | 2016 | 2 | 0.130 |
Why?
| | Emergency Medical Services | 1 | 2023 | 552 | 0.130 |
Why?
| | Patient Safety | 1 | 2020 | 314 | 0.130 |
Why?
| | Orthopedic Fixation Devices | 1 | 2016 | 7 | 0.130 |
Why?
| | Fever | 2 | 2017 | 306 | 0.130 |
Why?
| | Dementia | 1 | 2000 | 259 | 0.130 |
Why?
| | Shoulder Fractures | 1 | 2016 | 14 | 0.130 |
Why?
| | Medical History Taking | 2 | 2014 | 117 | 0.120 |
Why?
| | Elbow Joint | 1 | 2016 | 71 | 0.120 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2018 | 267 | 0.120 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2014 | 179 | 0.120 |
Why?
| | Child, Preschool | 18 | 2018 | 11074 | 0.120 |
Why?
| | Femoral Neck Fractures | 1 | 2015 | 21 | 0.120 |
Why?
| | Diagnosis, Differential | 4 | 2018 | 1483 | 0.120 |
Why?
| | Glomerular Filtration Rate | 6 | 2020 | 746 | 0.120 |
Why?
| | Case-Control Studies | 3 | 2019 | 3556 | 0.120 |
Why?
| | Lung Diseases | 2 | 2001 | 767 | 0.120 |
Why?
| | Femoral Neoplasms | 1 | 2015 | 9 | 0.120 |
Why?
| | Kidney Failure, Chronic | 3 | 2018 | 570 | 0.120 |
Why?
| | Tendinopathy | 1 | 2015 | 27 | 0.120 |
Why?
| | Respiratory Mechanics | 1 | 1995 | 67 | 0.120 |
Why?
| | Military Personnel | 2 | 2020 | 544 | 0.120 |
Why?
| | Limb Salvage | 1 | 2015 | 57 | 0.110 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2014 | 11 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 350 | 0.110 |
Why?
| | Fracture Fixation | 1 | 2015 | 75 | 0.110 |
Why?
| | Hemodilution | 1 | 2014 | 10 | 0.110 |
Why?
| | Journal Impact Factor | 1 | 2014 | 28 | 0.110 |
Why?
| | Ontario | 3 | 2023 | 148 | 0.110 |
Why?
| | Menstrual Cycle | 1 | 1995 | 133 | 0.110 |
Why?
| | Arthritis | 2 | 2016 | 95 | 0.110 |
Why?
| | Hemostasis, Surgical | 1 | 2014 | 22 | 0.110 |
Why?
| | Tachycardia | 4 | 1989 | 57 | 0.110 |
Why?
| | Spinal Stenosis | 1 | 2014 | 30 | 0.110 |
Why?
| | Tourniquets | 1 | 2014 | 24 | 0.110 |
Why?
| | Running | 1 | 2016 | 230 | 0.110 |
Why?
| | Intervertebral Disc Displacement | 1 | 2014 | 40 | 0.110 |
Why?
| | Laser Coagulation | 1 | 2014 | 68 | 0.110 |
Why?
| | Hemostatics | 1 | 2014 | 52 | 0.110 |
Why?
| | Professional Practice | 1 | 2014 | 64 | 0.110 |
Why?
| | Circadian Rhythm | 2 | 2016 | 468 | 0.110 |
Why?
| | Electromyography | 1 | 2016 | 400 | 0.110 |
Why?
| | Diagnostic Imaging | 2 | 2014 | 332 | 0.110 |
Why?
| | Malnutrition | 1 | 2015 | 83 | 0.110 |
Why?
| | Prostheses and Implants | 1 | 2015 | 143 | 0.110 |
Why?
| | Blood Component Transfusion | 1 | 2014 | 84 | 0.110 |
Why?
| | Pressure | 1 | 2014 | 225 | 0.100 |
Why?
| | Prosthesis Implantation | 1 | 2015 | 153 | 0.100 |
Why?
| | Arrhythmias, Cardiac | 5 | 2001 | 333 | 0.100 |
Why?
| | Canada | 1 | 2014 | 418 | 0.100 |
Why?
| | Learning Curve | 1 | 2013 | 72 | 0.100 |
Why?
| | Athletic Performance | 1 | 2014 | 79 | 0.100 |
Why?
| | Health Status Disparities | 1 | 2016 | 289 | 0.100 |
Why?
| | Societies, Medical | 2 | 2014 | 820 | 0.100 |
Why?
| | Gait | 1 | 2016 | 296 | 0.100 |
Why?
| | Metals | 1 | 2014 | 136 | 0.100 |
Why?
| | Adrenal Cortex Hormones | 2 | 2015 | 565 | 0.100 |
Why?
| | Multivariate Analysis | 5 | 2017 | 1509 | 0.100 |
Why?
| | Arthrometry, Articular | 1 | 2012 | 9 | 0.100 |
Why?
| | Watchful Waiting | 1 | 2012 | 81 | 0.100 |
Why?
| | Incidental Findings | 1 | 2013 | 87 | 0.100 |
Why?
| | Popliteal Vein | 1 | 2012 | 4 | 0.100 |
Why?
| | Pneumonia | 1 | 2018 | 639 | 0.100 |
Why?
| | Registries | 2 | 2018 | 2035 | 0.100 |
Why?
| | Ultrasonography | 3 | 2022 | 759 | 0.090 |
Why?
| | Posterior Cruciate Ligament | 1 | 2012 | 13 | 0.090 |
Why?
| | Nutritional Status | 1 | 2015 | 350 | 0.090 |
Why?
| | Locomotion | 1 | 2012 | 106 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1639 | 0.090 |
Why?
| | Periodicals as Topic | 1 | 2014 | 211 | 0.090 |
Why?
| | Circumcision, Male | 1 | 2011 | 14 | 0.090 |
Why?
| | Educational Measurement | 1 | 2014 | 289 | 0.090 |
Why?
| | Popliteal Artery | 1 | 2012 | 59 | 0.090 |
Why?
| | Diagnostic Errors | 1 | 2012 | 170 | 0.090 |
Why?
| | Prednisone | 3 | 2007 | 240 | 0.090 |
Why?
| | Osseointegration | 1 | 2012 | 71 | 0.090 |
Why?
| | Proteinuria | 3 | 2007 | 97 | 0.090 |
Why?
| | Practice Guidelines as Topic | 3 | 2025 | 1587 | 0.090 |
Why?
| | Policy Making | 1 | 2011 | 98 | 0.090 |
Why?
| | Tooth | 2 | 1990 | 42 | 0.090 |
Why?
| | Sexual Behavior | 1 | 2015 | 485 | 0.090 |
Why?
| | Disability Evaluation | 1 | 2012 | 290 | 0.090 |
Why?
| | Smoking | 1 | 2018 | 1627 | 0.090 |
Why?
| | Interleukin-7 | 1 | 2010 | 61 | 0.080 |
Why?
| | Ankle Joint | 2 | 2023 | 114 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 2 | 2014 | 1313 | 0.080 |
Why?
| | Reference Standards | 1 | 2010 | 186 | 0.080 |
Why?
| | Preventive Health Services | 1 | 2011 | 148 | 0.080 |
Why?
| | Upper Extremity | 1 | 2010 | 99 | 0.080 |
Why?
| | Lead | 1 | 1990 | 64 | 0.080 |
Why?
| | Bicuspid | 2 | 1988 | 17 | 0.080 |
Why?
| | Molar | 2 | 1988 | 49 | 0.080 |
Why?
| | Cancer Vaccines | 1 | 2010 | 172 | 0.080 |
Why?
| | Fractures, Bone | 1 | 2014 | 380 | 0.080 |
Why?
| | Vascular Surgical Procedures | 1 | 2012 | 303 | 0.080 |
Why?
| | Biopsy, Needle | 1 | 2009 | 189 | 0.070 |
Why?
| | Referral and Consultation | 2 | 2012 | 786 | 0.070 |
Why?
| | Naturopathy | 1 | 2008 | 1 | 0.070 |
Why?
| | Transplant Recipients | 2 | 2022 | 184 | 0.070 |
Why?
| | Pesticide Residues | 1 | 1988 | 4 | 0.070 |
Why?
| | Sepsis | 1 | 2015 | 617 | 0.070 |
Why?
| | Transillumination | 1 | 1988 | 3 | 0.070 |
Why?
| | Mexico | 2 | 2004 | 225 | 0.070 |
Why?
| | Urologic Diseases | 1 | 2008 | 41 | 0.070 |
Why?
| | Heart Arrest | 2 | 2012 | 339 | 0.070 |
Why?
| | Urography | 2 | 1998 | 17 | 0.070 |
Why?
| | Quality Improvement | 1 | 2016 | 1178 | 0.070 |
Why?
| | Neuropsychological Tests | 2 | 2019 | 1023 | 0.070 |
Why?
| | Spirometry | 2 | 2001 | 281 | 0.070 |
Why?
| | Insecticides | 1 | 1988 | 38 | 0.070 |
Why?
| | Rheumatoid Factor | 3 | 2025 | 175 | 0.070 |
Why?
| | Glomerulonephritis, Membranous | 1 | 2007 | 2 | 0.070 |
Why?
| | Leptospira interrogans | 2 | 1985 | 4 | 0.070 |
Why?
| | Systole | 2 | 2019 | 189 | 0.070 |
Why?
| | Diagnostic Tests, Routine | 1 | 2008 | 110 | 0.070 |
Why?
| | Dental Caries | 2 | 1988 | 155 | 0.070 |
Why?
| | Hospitalization | 3 | 2016 | 2199 | 0.070 |
Why?
| | Ginkgo biloba | 1 | 2007 | 8 | 0.070 |
Why?
| | Severity of Illness Index | 5 | 2016 | 2828 | 0.070 |
Why?
| | Creatinine | 3 | 2008 | 499 | 0.070 |
Why?
| | Logistic Models | 3 | 2015 | 2074 | 0.070 |
Why?
| | HLA-DR Antigens | 2 | 1997 | 228 | 0.060 |
Why?
| | Lysholm Knee Score | 2 | 2016 | 8 | 0.060 |
Why?
| | Milk, Human | 1 | 1988 | 158 | 0.060 |
Why?
| | Reagent Strips | 1 | 2006 | 8 | 0.060 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2001 | 652 | 0.060 |
Why?
| | Fatigue | 1 | 2008 | 329 | 0.060 |
Why?
| | Urine | 1 | 2006 | 59 | 0.060 |
Why?
| | Depressive Disorder | 2 | 2006 | 379 | 0.060 |
Why?
| | Dental Enamel | 3 | 1990 | 70 | 0.060 |
Why?
| | Ligaments | 2 | 2020 | 60 | 0.060 |
Why?
| | Sleep | 2 | 2022 | 755 | 0.060 |
Why?
| | Nephrosis, Lipoid | 1 | 2005 | 10 | 0.060 |
Why?
| | Obesity | 1 | 2018 | 2992 | 0.060 |
Why?
| | Return to Work | 2 | 2015 | 21 | 0.060 |
Why?
| | Hyperparathyroidism | 1 | 2004 | 10 | 0.060 |
Why?
| | Plant Extracts | 1 | 2007 | 202 | 0.060 |
Why?
| | Patient Selection | 2 | 2025 | 696 | 0.060 |
Why?
| | Shoulder Pain | 2 | 2018 | 34 | 0.060 |
Why?
| | Lung | 2 | 1995 | 4060 | 0.060 |
Why?
| | History, 21st Century | 1 | 2025 | 213 | 0.060 |
Why?
| | Leukocytes | 1 | 2006 | 311 | 0.060 |
Why?
| | Probability | 2 | 2006 | 304 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2008 | 496 | 0.050 |
Why?
| | Maternal Age | 1 | 2004 | 129 | 0.050 |
Why?
| | Weil Disease | 1 | 1983 | 1 | 0.050 |
Why?
| | Acidosis, Renal Tubular | 1 | 2003 | 4 | 0.050 |
Why?
| | Regression Analysis | 4 | 2016 | 1024 | 0.050 |
Why?
| | Joint Capsule | 2 | 2016 | 10 | 0.050 |
Why?
| | Health Status | 2 | 2008 | 792 | 0.050 |
Why?
| | Peripheral Nerve Injuries | 2 | 2017 | 36 | 0.050 |
Why?
| | Parathyroid Hormone | 1 | 2004 | 108 | 0.050 |
Why?
| | Social Justice | 1 | 2004 | 73 | 0.050 |
Why?
| | Failure to Thrive | 1 | 2003 | 29 | 0.050 |
Why?
| | Radionuclide Angiography | 2 | 2001 | 5 | 0.050 |
Why?
| | Bicarbonates | 1 | 2003 | 44 | 0.050 |
Why?
| | Felodipine | 1 | 2003 | 4 | 0.050 |
Why?
| | Blood Chemical Analysis | 1 | 2003 | 99 | 0.050 |
Why?
| | Vesico-Ureteral Reflux | 1 | 2003 | 32 | 0.050 |
Why?
| | Immobilization | 1 | 2023 | 43 | 0.050 |
Why?
| | Antibodies, Bacterial | 1 | 1983 | 146 | 0.050 |
Why?
| | Urinalysis | 2 | 2016 | 77 | 0.050 |
Why?
| | Injections | 1 | 2023 | 183 | 0.050 |
Why?
| | Nutrition Surveys | 1 | 2024 | 266 | 0.050 |
Why?
| | Evaluation Studies as Topic | 3 | 1998 | 180 | 0.050 |
Why?
| | Receptors, Cholecystokinin | 1 | 2002 | 8 | 0.050 |
Why?
| | Indoleacetic Acids | 1 | 2002 | 10 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2023 | 329 | 0.050 |
Why?
| | Dyslipidemias | 1 | 2024 | 176 | 0.050 |
Why?
| | Hormone Antagonists | 1 | 2002 | 34 | 0.050 |
Why?
| | Tomography, Emission-Computed | 1 | 2002 | 66 | 0.050 |
Why?
| | Nephritis, Hereditary | 1 | 2002 | 2 | 0.050 |
Why?
| | Enalapril | 1 | 2002 | 16 | 0.050 |
Why?
| | American Heart Association | 1 | 2023 | 306 | 0.050 |
Why?
| | Infant | 8 | 2013 | 9465 | 0.050 |
Why?
| | Emergencies | 1 | 2023 | 164 | 0.050 |
Why?
| | Environmental Exposure | 2 | 2001 | 579 | 0.050 |
Why?
| | Thiazoles | 1 | 2002 | 123 | 0.050 |
Why?
| | Nitrites | 1 | 2002 | 84 | 0.050 |
Why?
| | Forecasting | 1 | 2023 | 389 | 0.050 |
Why?
| | Vaccines, Conjugate | 1 | 2002 | 65 | 0.050 |
Why?
| | Radiopharmaceuticals | 1 | 2002 | 178 | 0.050 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2002 | 135 | 0.050 |
Why?
| | Airway Resistance | 1 | 2001 | 41 | 0.050 |
Why?
| | Meningococcal Vaccines | 1 | 2002 | 55 | 0.050 |
Why?
| | Confidence Intervals | 2 | 2016 | 329 | 0.040 |
Why?
| | Analysis of Variance | 4 | 2011 | 1316 | 0.040 |
Why?
| | Weight-Bearing | 2 | 2013 | 173 | 0.040 |
Why?
| | Dentin | 2 | 1990 | 24 | 0.040 |
Why?
| | Sensitivity and Specificity | 3 | 2018 | 1946 | 0.040 |
Why?
| | Urinary Tract Infections | 1 | 2003 | 188 | 0.040 |
Why?
| | Albuminuria | 1 | 2002 | 185 | 0.040 |
Why?
| | Respiration | 1 | 2001 | 199 | 0.040 |
Why?
| | Bartter Syndrome | 1 | 2000 | 8 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 201 | 0.040 |
Why?
| | Antibiotic Prophylaxis | 1 | 2002 | 119 | 0.040 |
Why?
| | Heart Function Tests | 1 | 2000 | 59 | 0.040 |
Why?
| | Cognition | 2 | 2007 | 1153 | 0.040 |
Why?
| | Heart Diseases | 1 | 2004 | 346 | 0.040 |
Why?
| | Pneumococcal Vaccines | 1 | 2002 | 142 | 0.040 |
Why?
| | Poverty | 1 | 2004 | 521 | 0.040 |
Why?
| | Renal Artery Obstruction | 1 | 2000 | 30 | 0.040 |
Why?
| | Renal Artery | 1 | 2000 | 37 | 0.040 |
Why?
| | Mental Status Schedule | 1 | 2000 | 33 | 0.040 |
Why?
| | Language Tests | 1 | 2000 | 23 | 0.040 |
Why?
| | Consumer Product Safety | 1 | 2020 | 33 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2001 | 2031 | 0.040 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 1999 | 22 | 0.040 |
Why?
| | HIV Infections | 2 | 2011 | 2836 | 0.040 |
Why?
| | Seizures | 1 | 2023 | 426 | 0.040 |
Why?
| | Bacterial Infections | 1 | 2002 | 250 | 0.040 |
Why?
| | Aggrecans | 1 | 2019 | 14 | 0.040 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2003 | 262 | 0.040 |
Why?
| | Quality of Life | 2 | 2015 | 2892 | 0.040 |
Why?
| | Pediatrics | 2 | 2024 | 1101 | 0.040 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 179 | 0.040 |
Why?
| | Survival Rate | 2 | 2001 | 1972 | 0.040 |
Why?
| | Vitamin E | 1 | 1999 | 124 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2002 | 480 | 0.040 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2019 | 17 | 0.040 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 87 | 0.040 |
Why?
| | Depression | 1 | 2008 | 1397 | 0.040 |
Why?
| | United Kingdom | 1 | 2020 | 318 | 0.040 |
Why?
| | Urinary Bladder | 2 | 1998 | 183 | 0.040 |
Why?
| | Diastole | 1 | 2019 | 149 | 0.040 |
Why?
| | Proteoglycans | 1 | 2019 | 107 | 0.040 |
Why?
| | Serum | 1 | 2019 | 59 | 0.040 |
Why?
| | Research Subjects | 1 | 2018 | 42 | 0.040 |
Why?
| | Calcium | 1 | 2004 | 1199 | 0.040 |
Why?
| | ROC Curve | 1 | 2000 | 554 | 0.040 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2001 | 238 | 0.040 |
Why?
| | Thigh | 1 | 2018 | 48 | 0.040 |
Why?
| | Deltoid Muscle | 1 | 2017 | 6 | 0.040 |
Why?
| | Benzophenones | 1 | 2017 | 16 | 0.040 |
Why?
| | Cystoscopy | 1 | 1998 | 21 | 0.040 |
Why?
| | Pectoralis Muscles | 1 | 2017 | 18 | 0.040 |
Why?
| | Radiographic Image Enhancement | 1 | 1998 | 58 | 0.040 |
Why?
| | Anatomic Landmarks | 1 | 2017 | 29 | 0.040 |
Why?
| | Sciatic Nerve | 1 | 2018 | 58 | 0.040 |
Why?
| | Demography | 1 | 2018 | 291 | 0.030 |
Why?
| | Dissection | 1 | 2018 | 52 | 0.030 |
Why?
| | Brachial Plexus | 1 | 2017 | 29 | 0.030 |
Why?
| | HLA-DP Antigens | 1 | 1997 | 33 | 0.030 |
Why?
| | Torque | 1 | 2017 | 84 | 0.030 |
Why?
| | Ketones | 1 | 2017 | 49 | 0.030 |
Why?
| | Biomarkers | 3 | 2019 | 4149 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2000 | 1266 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2025 | 2833 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2022 | 655 | 0.030 |
Why?
| | Tarsal Bones | 1 | 2016 | 13 | 0.030 |
Why?
| | Glucose | 1 | 2002 | 1020 | 0.030 |
Why?
| | White Coat Hypertension | 1 | 2016 | 7 | 0.030 |
Why?
| | User-Computer Interface | 1 | 1998 | 159 | 0.030 |
Why?
| | HLA-DQ Antigens | 1 | 1997 | 181 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2019 | 275 | 0.030 |
Why?
| | Respiratory Function Tests | 2 | 1996 | 600 | 0.030 |
Why?
| | Neuroimaging | 1 | 2019 | 259 | 0.030 |
Why?
| | Hominidae | 1 | 1997 | 85 | 0.030 |
Why?
| | Inspiratory Capacity | 1 | 1996 | 3 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1793 | 0.030 |
Why?
| | Atmosphere Exposure Chambers | 1 | 1995 | 7 | 0.030 |
Why?
| | Frontal Lobe | 1 | 1997 | 149 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1208 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 425 | 0.030 |
Why?
| | Antioxidants | 1 | 1999 | 584 | 0.030 |
Why?
| | Lung Volume Measurements | 1 | 1995 | 46 | 0.030 |
Why?
| | Hemodynamics | 1 | 2000 | 1113 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2016 | 157 | 0.030 |
Why?
| | Synovitis, Pigmented Villonodular | 1 | 2015 | 3 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2004 | 6079 | 0.030 |
Why?
| | Endoscopy | 1 | 1998 | 318 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 2002 | 940 | 0.030 |
Why?
| | Ossification, Heterotopic | 1 | 2015 | 16 | 0.030 |
Why?
| | Pulmonary Ventilation | 1 | 1995 | 79 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 1995 | 145 | 0.030 |
Why?
| | Capillary Permeability | 1 | 1995 | 145 | 0.030 |
Why?
| | Contraindications | 1 | 2015 | 90 | 0.030 |
Why?
| | Dental Pulp | 1 | 1974 | 4 | 0.030 |
Why?
| | Remission, Spontaneous | 1 | 2014 | 40 | 0.030 |
Why?
| | Caregivers | 1 | 2022 | 877 | 0.030 |
Why?
| | Radiotherapy Dosage | 1 | 2015 | 268 | 0.030 |
Why?
| | Insurance, Health | 2 | 2014 | 283 | 0.030 |
Why?
| | Essential Hypertension | 1 | 2014 | 5 | 0.030 |
Why?
| | Vital Capacity | 1 | 1995 | 311 | 0.030 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 1995 | 142 | 0.030 |
Why?
| | Nutrition Assessment | 1 | 2015 | 92 | 0.030 |
Why?
| | Bronchoscopy | 1 | 1995 | 223 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 110 | 0.030 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 1994 | 19 | 0.030 |
Why?
| | Periodontitis | 1 | 1974 | 53 | 0.030 |
Why?
| | Pancreatic Neoplasms | 1 | 2002 | 938 | 0.030 |
Why?
| | Pregnancy | 2 | 2004 | 6763 | 0.030 |
Why?
| | Guided Tissue Regeneration | 1 | 2013 | 13 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 849 | 0.030 |
Why?
| | Urban Population | 2 | 1990 | 479 | 0.030 |
Why?
| | Private Practice | 1 | 2014 | 25 | 0.030 |
Why?
| | Bibliometrics | 1 | 2014 | 63 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 1995 | 531 | 0.030 |
Why?
| | Polymers | 1 | 2017 | 490 | 0.030 |
Why?
| | Outpatients | 1 | 2017 | 396 | 0.030 |
Why?
| | Educational Status | 2 | 2013 | 470 | 0.030 |
Why?
| | Biopsy | 3 | 2007 | 1129 | 0.030 |
Why?
| | Penile Diseases | 1 | 1993 | 6 | 0.030 |
Why?
| | Histoplasmosis | 1 | 1993 | 17 | 0.030 |
Why?
| | Acute Disease | 3 | 2015 | 1007 | 0.030 |
Why?
| | Electric Stimulation Therapy | 1 | 1994 | 81 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1325 | 0.030 |
Why?
| | Cervical Vertebrae | 1 | 2014 | 137 | 0.030 |
Why?
| | Academies and Institutes | 1 | 2013 | 53 | 0.030 |
Why?
| | Biological Evolution | 1 | 1997 | 474 | 0.020 |
Why?
| | Inpatients | 1 | 2017 | 500 | 0.020 |
Why?
| | France | 2 | 1990 | 33 | 0.020 |
Why?
| | Sarcoma | 1 | 2015 | 188 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 2017 | 641 | 0.020 |
Why?
| | Pulmonary Edema | 2 | 2012 | 108 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 1995 | 513 | 0.020 |
Why?
| | Exercise Test | 1 | 1995 | 625 | 0.020 |
Why?
| | Bone Neoplasms | 1 | 2015 | 247 | 0.020 |
Why?
| | North America | 1 | 2013 | 313 | 0.020 |
Why?
| | Sterilization | 1 | 2012 | 23 | 0.020 |
Why?
| | Personal Health Services | 1 | 1991 | 1 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 382 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1066 | 0.020 |
Why?
| | Intestinal Obstruction | 2 | 1991 | 51 | 0.020 |
Why?
| | Papua New Guinea | 1 | 2011 | 9 | 0.020 |
Why?
| | Gamma Rays | 1 | 2012 | 57 | 0.020 |
Why?
| | Health Planning Guidelines | 1 | 2011 | 25 | 0.020 |
Why?
| | Medicare | 1 | 2017 | 773 | 0.020 |
Why?
| | Temporomandibular Joint | 1 | 1991 | 8 | 0.020 |
Why?
| | Denture, Complete | 1 | 1991 | 7 | 0.020 |
Why?
| | Mouth, Edentulous | 1 | 1991 | 10 | 0.020 |
Why?
| | Dentition | 1 | 1991 | 17 | 0.020 |
Why?
| | Mental Disorders | 1 | 2000 | 1077 | 0.020 |
Why?
| | Joint Capsule Release | 1 | 2011 | 2 | 0.020 |
Why?
| | Animals | 6 | 2019 | 36940 | 0.020 |
Why?
| | World Health Organization | 1 | 2011 | 123 | 0.020 |
Why?
| | Health Literacy | 1 | 2013 | 168 | 0.020 |
Why?
| | B7-1 Antigen | 1 | 2010 | 58 | 0.020 |
Why?
| | Rhabdomyosarcoma | 1 | 1991 | 72 | 0.020 |
Why?
| | Retinoids | 1 | 1990 | 34 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2015 | 911 | 0.020 |
Why?
| | Epidemiologic Methods | 2 | 1988 | 97 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 1692 | 0.020 |
Why?
| | Rabbits | 1 | 2012 | 794 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 14 | 0.020 |
Why?
| | Guanylate Cyclase | 1 | 1990 | 37 | 0.020 |
Why?
| | Intestine, Small | 1 | 1991 | 156 | 0.020 |
Why?
| | Substance Abuse, Intravenous | 1 | 1991 | 115 | 0.020 |
Why?
| | Models, Animal | 1 | 2012 | 384 | 0.020 |
Why?
| | Bone Diseases | 1 | 1990 | 62 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2024 | 2531 | 0.020 |
Why?
| | Health Services Needs and Demand | 1 | 2011 | 273 | 0.020 |
Why?
| | HLA Antigens | 1 | 2010 | 240 | 0.020 |
Why?
| | Equipment Failure | 1 | 2009 | 108 | 0.020 |
Why?
| | New York | 1 | 2009 | 126 | 0.020 |
Why?
| | Blood Urea Nitrogen | 1 | 2008 | 54 | 0.020 |
Why?
| | Fourier Analysis | 2 | 2001 | 40 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1092 | 0.020 |
Why?
| | Health Services Research | 1 | 2011 | 404 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1989 | 114 | 0.020 |
Why?
| | DDT | 1 | 1988 | 2 | 0.020 |
Why?
| | Polychlorinated Biphenyls | 1 | 1988 | 12 | 0.020 |
Why?
| | Tooth, Deciduous | 1 | 1988 | 18 | 0.020 |
Why?
| | Transfection | 1 | 2010 | 945 | 0.020 |
Why?
| | Preoperative Care | 1 | 2010 | 362 | 0.020 |
Why?
| | Health Policy | 1 | 2011 | 388 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 482 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2008 | 120 | 0.020 |
Why?
| | Michigan | 2 | 1985 | 109 | 0.020 |
Why?
| | HLA-DRB1 Chains | 2 | 1997 | 112 | 0.020 |
Why?
| | Capsules | 1 | 2007 | 38 | 0.020 |
Why?
| | Lithotripsy | 1 | 2007 | 48 | 0.020 |
Why?
| | Placebos | 1 | 2007 | 199 | 0.020 |
Why?
| | Reference Values | 2 | 2000 | 816 | 0.020 |
Why?
| | Phytotherapy | 1 | 2007 | 83 | 0.020 |
Why?
| | Public Health | 1 | 2011 | 588 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2007 | 108 | 0.020 |
Why?
| | Rodent Control | 1 | 1985 | 2 | 0.020 |
Why?
| | Angiography | 2 | 2000 | 207 | 0.020 |
Why?
| | Leptospirosis | 1 | 1985 | 8 | 0.020 |
Why?
| | Tooth Diseases | 1 | 1985 | 13 | 0.020 |
Why?
| | Cytokines | 1 | 2013 | 2085 | 0.010 |
Why?
| | Cardiomyopathies | 1 | 1989 | 350 | 0.010 |
Why?
| | Tooth Extraction | 1 | 1985 | 25 | 0.010 |
Why?
| | Rural Population | 1 | 1990 | 563 | 0.010 |
Why?
| | Amiodarone | 1 | 1985 | 26 | 0.010 |
Why?
| | Blood Gas Analysis | 2 | 2003 | 74 | 0.010 |
Why?
| | Benzofurans | 1 | 1985 | 21 | 0.010 |
Why?
| | Memory | 1 | 2007 | 248 | 0.010 |
Why?
| | Attitude to Health | 1 | 2008 | 439 | 0.010 |
Why?
| | Alleles | 2 | 1997 | 891 | 0.010 |
Why?
| | Inflammation | 1 | 1995 | 2837 | 0.010 |
Why?
| | Suburban Population | 1 | 1983 | 17 | 0.010 |
Why?
| | Self Concept | 1 | 2006 | 253 | 0.010 |
Why?
| | Hematocrit | 1 | 2004 | 96 | 0.010 |
Why?
| | Serum Albumin | 1 | 2004 | 150 | 0.010 |
Why?
| | Exercise | 1 | 1995 | 2057 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 2057 | 0.010 |
Why?
| | Occupational Diseases | 1 | 1985 | 156 | 0.010 |
Why?
| | Decision Making | 1 | 2011 | 900 | 0.010 |
Why?
| | Attention | 1 | 2007 | 427 | 0.010 |
Why?
| | Wounds and Injuries | 1 | 2010 | 758 | 0.010 |
Why?
| | Bronchopneumonia | 2 | 1973 | 6 | 0.010 |
Why?
| | Learning | 1 | 2007 | 409 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3412 | 0.010 |
Why?
| | Coronary Disease | 1 | 1985 | 385 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2003 | 181 | 0.010 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2002 | 13 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1996 | 0.010 |
Why?
| | Technetium | 1 | 2001 | 10 | 0.010 |
Why?
| | Likelihood Functions | 1 | 2001 | 144 | 0.010 |
Why?
| | Ifosfamide | 1 | 1999 | 37 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2004 | 594 | 0.010 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 1999 | 74 | 0.010 |
Why?
| | Death, Sudden, Cardiac | 1 | 2001 | 185 | 0.010 |
Why?
| | Etoposide | 1 | 1999 | 158 | 0.010 |
Why?
| | Carboplatin | 1 | 1999 | 144 | 0.010 |
Why?
| | Collagen | 2 | 1991 | 452 | 0.010 |
Why?
| | Combined Modality Therapy | 2 | 1994 | 1236 | 0.010 |
Why?
| | Cause of Death | 1 | 2000 | 434 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1999 | 686 | 0.010 |
Why?
| | Stroke Volume | 1 | 2001 | 612 | 0.010 |
Why?
| | HLA-DQ beta-Chains | 1 | 1997 | 63 | 0.010 |
Why?
| | Prevalence | 1 | 2004 | 2734 | 0.010 |
Why?
| | Histocompatibility Testing | 1 | 1997 | 126 | 0.010 |
Why?
| | Animals, Zoo | 1 | 1997 | 12 | 0.010 |
Why?
| | Hylobates | 1 | 1997 | 8 | 0.010 |
Why?
| | Pongo pygmaeus | 1 | 1997 | 7 | 0.010 |
Why?
| | Ileum | 1 | 1998 | 119 | 0.010 |
Why?
| | HLA-DP beta-Chains | 1 | 1997 | 86 | 0.010 |
Why?
| | Gorilla gorilla | 1 | 1997 | 23 | 0.010 |
Why?
| | Pan troglodytes | 1 | 1997 | 63 | 0.010 |
Why?
| | Linkage Disequilibrium | 1 | 1997 | 268 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 1999 | 558 | 0.010 |
Why?
| | Hypoxia | 3 | 1973 | 1112 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 1997 | 307 | 0.010 |
Why?
| | Macaca mulatta | 1 | 1997 | 166 | 0.010 |
Why?
| | Gene Frequency | 1 | 1997 | 521 | 0.010 |
Why?
| | Haplotypes | 1 | 1997 | 494 | 0.010 |
Why?
| | Species Specificity | 1 | 1997 | 585 | 0.010 |
Why?
| | Electric Impedance | 1 | 1996 | 107 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 1997 | 347 | 0.010 |
Why?
| | Erythrocytes | 1 | 2001 | 700 | 0.010 |
Why?
| | Heart Conduction System | 2 | 1989 | 99 | 0.010 |
Why?
| | Stem Cells | 1 | 1999 | 594 | 0.010 |
Why?
| | Cell Movement | 1 | 1999 | 967 | 0.010 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 1996 | 145 | 0.010 |
Why?
| | Dental Pulp Test | 1 | 1974 | 1 | 0.010 |
Why?
| | Alveolar Process | 1 | 1974 | 6 | 0.010 |
Why?
| | Tooth Mobility | 1 | 1974 | 6 | 0.010 |
Why?
| | Health Behavior | 1 | 2000 | 762 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1997 | 660 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1997 | 812 | 0.010 |
Why?
| | Equipment Design | 1 | 1996 | 522 | 0.010 |
Why?
| | Penis | 1 | 1993 | 36 | 0.010 |
Why?
| | New York City | 1 | 1993 | 85 | 0.010 |
Why?
| | Temperature | 1 | 1996 | 679 | 0.010 |
Why?
| | Nerve Endings | 1 | 1972 | 4 | 0.010 |
Why?
| | Rib Fractures | 1 | 1972 | 32 | 0.010 |
Why?
| | Baltimore | 1 | 1991 | 60 | 0.010 |
Why?
| | Mandibular Condyle | 1 | 1991 | 6 | 0.010 |
Why?
| | Connective Tissue | 1 | 1991 | 36 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1972 | 443 | 0.010 |
Why?
| | CD4 Antigens | 1 | 1991 | 141 | 0.010 |
Why?
| | Temporal Bone | 1 | 1991 | 45 | 0.010 |
Why?
| | Atrophy | 1 | 1991 | 184 | 0.010 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 88 | 0.010 |
Why?
| | Nitroprusside | 1 | 1990 | 69 | 0.010 |
Why?
| | Income | 1 | 1991 | 202 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1990 | 127 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 345 | 0.010 |
Why?
| | Solubility | 1 | 1990 | 245 | 0.010 |
Why?
| | Immunoblotting | 1 | 1990 | 308 | 0.010 |
Why?
| | Disease Progression | 1 | 1997 | 2757 | 0.000 |
Why?
| | Syncope | 1 | 1989 | 52 | 0.000 |
Why?
| | Skin Diseases | 1 | 1990 | 149 | 0.000 |
Why?
| | Cardiac Pacing, Artificial | 1 | 1989 | 87 | 0.000 |
Why?
| | Calcinosis | 1 | 1990 | 235 | 0.000 |
Why?
| | Enzyme Activation | 1 | 1990 | 810 | 0.000 |
Why?
| | Cattle | 1 | 1990 | 984 | 0.000 |
Why?
| | Osteoporosis | 1 | 1990 | 243 | 0.000 |
Why?
| | Psychotropic Drugs | 1 | 1986 | 68 | 0.000 |
Why?
| | Absenteeism | 1 | 1986 | 49 | 0.000 |
Why?
| | Oral Surgical Procedures, Preprosthetic | 1 | 1985 | 1 | 0.000 |
Why?
| | Tooth Injuries | 1 | 1985 | 4 | 0.000 |
Why?
| | Tooth Eruption | 1 | 1985 | 10 | 0.000 |
Why?
| | Malocclusion | 1 | 1985 | 24 | 0.000 |
Why?
| | Periodontal Diseases | 1 | 1985 | 61 | 0.000 |
Why?
| | Ambulatory Care | 1 | 1986 | 546 | 0.000 |
Why?
| | Asthma | 1 | 1996 | 2295 | 0.000 |
Why?
| | Heart Aneurysm | 1 | 1982 | 11 | 0.000 |
Why?
| | Cryosurgery | 1 | 1982 | 59 | 0.000 |
Why?
| | Hypotension | 2 | 1972 | 122 | 0.000 |
Why?
| | Streptococcal Infections | 2 | 1973 | 151 | 0.000 |
Why?
| | Carbon Dioxide | 2 | 1973 | 267 | 0.000 |
Why?
| | Suicide | 1 | 1986 | 656 | 0.000 |
Why?
| | Respiration, Artificial | 2 | 1972 | 645 | 0.000 |
Why?
| | Rats | 1 | 1985 | 5647 | 0.000 |
Why?
| | Acid-Base Equilibrium | 1 | 1973 | 28 | 0.000 |
Why?
| | Positive-Pressure Respiration | 1 | 1973 | 80 | 0.000 |
Why?
| | Neurologic Manifestations | 1 | 1972 | 3 | 0.000 |
Why?
| | Anuria | 1 | 1972 | 4 | 0.000 |
Why?
| | Drowning | 1 | 1972 | 6 | 0.000 |
Why?
| | Embolism, Fat | 1 | 1972 | 11 | 0.000 |
Why?
| | Tracheotomy | 1 | 1972 | 23 | 0.000 |
Why?
| | Cyanosis | 1 | 1972 | 16 | 0.000 |
Why?
| | Mitral Valve Stenosis | 1 | 1972 | 18 | 0.000 |
Why?
| | Anti-Bacterial Agents | 2 | 1973 | 1809 | 0.000 |
Why?
| | Pneumococcal Infections | 1 | 1973 | 115 | 0.000 |
Why?
| | Blood Proteins | 1 | 1973 | 252 | 0.000 |
Why?
| | Shock | 1 | 1972 | 98 | 0.000 |
Why?
| | Heparin | 1 | 1972 | 261 | 0.000 |
Why?
| | Resuscitation | 1 | 1972 | 251 | 0.000 |
Why?
| | Hemorrhage | 1 | 1972 | 722 | 0.000 |
Why?
| | Oxygen | 1 | 1972 | 931 | 0.000 |
Why?
| | Pneumonia, Viral | 1 | 1972 | 373 | 0.000 |
Why?
| | Influenza, Human | 1 | 1973 | 622 | 0.000 |
Why?
| | Alcoholism | 1 | 1972 | 807 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|